ArticleExperimental and therapeutic medicine2016

Penehyclidine ameliorates acute lung injury by inhibiting Toll-like receptor 2/4 expression and nuclear factor-κB activation.

N A Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.